Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Centocor Ortho Biotech Products withdraws NDA for trabectedin for treatment of women with ROC

Centocor Ortho Biotech Products withdraws NDA for trabectedin for treatment of women with ROC

Celgene non-GAAP total revenue increases 40% to $1.11 billion

Celgene non-GAAP total revenue increases 40% to $1.11 billion

GPs could offer simple test for early detection of ovarian cancer

GPs could offer simple test for early detection of ovarian cancer

CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC

CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC

Motor regulatory protein can block human ovarian tumor growth

Motor regulatory protein can block human ovarian tumor growth

Colorectal cancer patients with genetic mutation can benefit from new class of drugs

Colorectal cancer patients with genetic mutation can benefit from new class of drugs

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

U.S. DOD awards $4.5M to NYU Langone Medical Center for novel breast cancer research

U.S. DOD awards $4.5M to NYU Langone Medical Center for novel breast cancer research

Sequencing the genomes of cancer patients help doctors decide the best course of treatment

Sequencing the genomes of cancer patients help doctors decide the best course of treatment

OSU biophysicist leverages computer cluster to develop drug to block small protein molecule IL-6

OSU biophysicist leverages computer cluster to develop drug to block small protein molecule IL-6

Ohio State biophysicist disrupts cellular messages through fragment-based drug design

Ohio State biophysicist disrupts cellular messages through fragment-based drug design

Study finds more evidence linking high-grade serous ovarian cancer to fallopian tubes

Study finds more evidence linking high-grade serous ovarian cancer to fallopian tubes

NVP-BEZ235 inhibits growth of ovarian cancer cells, increases survival: Study

NVP-BEZ235 inhibits growth of ovarian cancer cells, increases survival: Study

Major pharmaceutical company, Access sign deal for RNAi therapeutics

Major pharmaceutical company, Access sign deal for RNAi therapeutics

Protest over planned cuts to Australian medical research funding

Protest over planned cuts to Australian medical research funding

New treatment approach raises hope for women with ovarian cancer

New treatment approach raises hope for women with ovarian cancer

Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of human cancers

Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of human cancers

American Cancer Society awards 85 institutions with $49,213,000 for new research, training

American Cancer Society awards 85 institutions with $49,213,000 for new research, training

AACR President-elect to host press conference on cancer risk factors and genetics

AACR President-elect to host press conference on cancer risk factors and genetics

Women with ovarian cancer having BRCA2 gene mutations are more likely to survive

Women with ovarian cancer having BRCA2 gene mutations are more likely to survive

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.